Baker Brothers Advisors - KALA PHARMACEUTICALS INC ownership

KALA PHARMACEUTICALS INC's ticker is and the CUSIP is 483119202. A total of 25 filers reported holding KALA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of KALA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$2,372,856
+39.9%
266,613
+129.4%
0.01%
+40.0%
Q2 2023$1,695,548
+46.7%
116,213
+51.3%
0.01%
+66.7%
Q1 2023$1,156,036
-60.6%
76,8130.0%0.01%
-66.7%
Q4 2022$2,930,41676,8130.02%
Other shareholders
KALA PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Board of Trustees of The Leland Stanford Junior University 21,127$188,0300.02%
Baker Brothers Advisors 266,613$2,372,8560.01%
Covestor Ltd 1,325$120.01%
Knights of Columbus Asset Advisors LLC 2,417$21,5110.00%
MILLENNIUM MANAGEMENT LLC 134,354$1,195,7510.00%
Compagnie Lombard Odier SCmA 400$3,5600.00%
OSAIC HOLDINGS, INC. 234$2,0830.00%
DIMENSIONAL FUND ADVISORS LP 12,092$107,6190.00%
BANK OF AMERICA CORP /DE/ 115$1,0240.00%
WELLS FARGO & COMPANY/MN 16$1420.00%
View complete list of KALA PHARMACEUTICALS INC shareholders